Physician profile
Caleb Piatt
NPI 1194258335
$14,363.58
in general payments reported to CMS, 2019-2025
11 companies · $21.03 in 2025
The $21.03 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,238 · 2020: $63.45 · 2021: $158 · 2022: $4,962 · 2023: $2,729 · 2024: $2,192 · 2025: $21.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,174 · Food and Beverage: $1,767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,174.49 |
| Food and Beverage | $1,767.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $5,371.00 | 2019-2022 | |
| Titan Surgical Group, LLC | $4,563.55 | 2022-2024 | |
| Arthrex, INC. | $3,203.28 | 2023-2024 | |
| Stryker Corporation | $600.72 | 2023-2024 | Mako, Everest Spinal System, Spinemap |
| Zimmer Biomet Holdings, INC. | $173.22 | 2023 | Identity, Comprehensive Shoulder System |
| Smith+Nephew, INC. | $142.42 | 2022 | |
| Si-Bone, INC. | $113.36 | 2021 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $63.45 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $41.55 | 2021-2025 | Exparel |
| Avanos Medical | $24.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Piatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.